Metagenomics Sequencing Market to to Grow with a CAGR of 14.73% through 2031

The rise in research and development activities for the development of new drugs is expected to drive the growth of the Global Metagenomics Sequencing Market during the forecast period, 2027-2031.

According to TechSci Research report, “Metagenomics Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, The Global Metagenomics Sequencing Market will grow from USD 3.17 Billion in 2025 to USD 7.23 Billion by 2031 at a 14.73% CAGR. This can be ascribed to the research and development activities for the development of novel drugs and the growing demand for advanced sequencing technology across the region. Additionally, the increasing applications of metagenomics across fields such as bioremediation, ecological and environmental metagenomics, clinical diagnostics, drug development, and industrial use are major drivers of market growth during the forecast period. Additionally, the growing adoption of bioinformatics in diagnostic procedures and the increasing demand for the discovery of new proteins, such as antibiotics, through purification, cloning, and expression of DNA from organisms, will further drive growth in the Global Metagenomics Sequencing Market over the forecast period. Moreover, governments worldwide are supporting the development of the healthcare industry, including funding for research and development, thereby driving demand for the Metagenomics Sequencing Market during the forecast period.

However, the cost of metagenomics sequencing can be high, particularly for high-throughput sequencing technologies. This may slow the growth of the Global Metagenomics Sequencing Market during the forecast period. Also, Metagenomics sequencing generates vast amounts of data that can be difficult to analyze and interpret. Advanced bioinformatics tools and expertise are often required to extract meaningful insights from the data, creating a challenge that further restricts the growth of the Global Metagenomics Sequencing Market. Similarly, a lack of standardisation in metagenomics sequencing machines, along with Environmental samples, can contain diverse microbial communities with varying abundances, making it challenging to accurately capture and sequence the entire microbial diversity, which may hamper market growth during the forecast period.

Browse over XX market data Figures spread through xx Pages and an in-depth TOC on "Global Metagenomics Sequencing Market.”

Metagenomics Sequencing market is segmented into product and service, technology, application, regional distribution and company.

Based on Technology, 16S rRNA sequencing category is exhibiting the fastest growth within the Global Metagenomic Sequencing Market. This technique is increasingly favored due to its cost-effectiveness, simplicity, and suitability for profiling bacterial and archaeal communities in a wide range of environments. 16S rRNA sequencing targets the highly conserved 16S ribosomal RNA gene, which contains both conserved and variable regions, enabling taxonomic classification of microbes even in complex or previously uncharacterized samples. One of the main factors contributing to the growth of 16S rRNA sequencing is its widespread application in microbiome studies, clinical diagnostics, environmental surveillance, and agricultural research. It is especially valuable for identifying microbial diversity and relative abundance in ecosystems, human gut microbiota, and contaminated environments. Its use in human health, particularly in studying the gut microbiome and its associations with diseases such as obesity, diabetes, and inflammatory bowel disease, has brought this technology to the forefront.

Within the Asia-Pacific region, the market is experiencing the fastest growth in the global metagenomic sequencing market, primarily due to increasing investments in biotechnology, expanding healthcare infrastructure, and rising awareness of genomic technologies across emerging economies. Countries such as China, India, Japan, and South Korea are witnessing a surge in research activities, with governments and private institutions increasingly recognizing the potential of metagenomics in fields like disease diagnostics, agriculture, and environmental monitoring. In China, the government’s 13th Five-Year Plan for Science and Technology and similar initiatives have promoted genomics research and development, significantly contributing to the growth of sequencing technologies. Moreover, organizations like BGI Group have become major global players, investing heavily in sequencing platforms and research collaborations that expand the use of metagenomics across Asia and beyond. India, similarly, has increased funding in life sciences through initiatives such as the Department of Biotechnology’s Genome India Project, which aims to catalog genetic data from the Indian population and expand sequencing capabilities.

Major companies operating in the Global Metagenomics Sequencing Market are:

• BGI Genomics Co Ltd.
• Eurofins Scientific SE
• Illumina Inc.
• Macrogen, Inc.
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• PerkinElmer Inc.
• QIAGEN N.V.
• Swift Biosciences Inc.
• Thermo Fisher Scientific Inc.

Download Free Sample Report

Customers can also request a 10% free customisation on this report.

“North America is expected to dominate in the Global Metagenomics Sequencing Market due to the growing well-established healthcare infrastructure, along with growing demand for advanced sequencing techniques for easy detection of diseases across the region. Similarly, the growing interest of researchers in meta-transcriptomics, metabolomics, and metaproteomics, and investments in bioinformatics to promote metagenomics and microbiome research are expected to drive strong growth in the market during the forecast period. Additionally, growing concern about viral diseases such as hepatitis B, HIV/AIDS, influenza, and diarrhoea, along with increased research and development to identify viral disease genes, are expected to drive market growth during the forecast period. Furthermore, growing availability of technologically advanced products and robust sample processing and library preparation assay kits for exploring the genome activity , and the demand for efficient library preparation products will further be expected to create lucrative opportunities for market growth,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based global management consulting firm.

“Metagenomics Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Service (Reagents & consumables, Instruments, Services), By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics), By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications), By Region and Competition, 2021-2031F”, has evaluated the future growth potential of global Metagenomics Sequencing market and provides statistics & information on market size, structure, and future market growth. The report aims to provide up-to-date market intelligence and support decision-makers in making sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Global Metagenomics Sequencing market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com